Pharmacology of T-Cell Therapies, Volume 106 in the Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Topics in this new release include Enhancing persistence of therapeutic T cells, T cell manufacturing impacts on in vivo function, Transient T cell therapies, In vivo T cell therapies, T cell subsets for therapy, Engineering T cell metabolism to enhance therapeutic efficacy, and Tracking Therapeutic T cells In Vivo contacts.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Preface - p. xv 8. Chapter One: Fundamentals of engineered T cell therapies: From basic design to bells and whistles - p. 1 9. Chapter Two: T Cell subsets for therapy–unconventional CD1d-restricted natural killer T cells - p. 65 10. Chapter Three: Enhancing the persistence of therapeutic T cells - p. 101 11. Chapter Four: Engineering T cell metabolism to enhance therapeutic efficacy - p. 117 12. Chapter Five: Manufacturing as biology: How T-cell processing shapes therapeutic outcomes - p. 141 13. Chapter Six: Transient T cell therapies - p. 179 14. Chapter Seven: In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation - p. 213 15. Chapter Eight: Tracking therapeutic T cells in vivo - p. 253
Pharmacology of T-Cell Therapies, Volume 106 in the Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Topics in this new release include Enhancing persistence of therapeutic T cells, T cell manufacturing impacts on in vivo function, Transient T cell therapies, In vivo T cell therapies, T cell subsets for therapy, Engineering T cell metabolism to enhance therapeutic efficacy, and Tracking Therapeutic T cells In Vivo contacts.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Copyright - p. iv 6. Contributors - p. xi 7. Preface - p. xv 8. Chapter One: Fundamentals of engineered T cell therapies: From basic design to bells and whistles - p. 1 9. Chapter Two: T Cell subsets for therapy–unconventional CD1d-restricted natural killer T cells - p. 65 10. Chapter Three: Enhancing the persistence of therapeutic T cells - p. 101 11. Chapter Four: Engineering T cell metabolism to enhance therapeutic efficacy - p. 117 12. Chapter Five: Manufacturing as biology: How T-cell processing shapes therapeutic outcomes - p. 141 13. Chapter Six: Transient T cell therapies - p. 179 14. Chapter Seven: In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation - p. 213 15. Chapter Eight: Tracking therapeutic T cells in vivo - p. 253
